BioHackers Choice
HomeDisclaimerSign in
← Back to compounds
Image coming soon

— peptide / growth —

Sermorelin 5mg· 5mg

Synthetic 29-amino-acid N-terminal fragment of native GHRH investigated as the minimal bioactive sequence for growth hormone-releasing activity.

Guillemin (Nobel 1977) foundational GHRH. Frohman 1980s-90s. Geref clinical reports. Read more →

From Retail $46 USDT

Member $40.00 USDT

Members save 15% — free to join

⏱Sold Out — Longer wait

Order now to reserve — we'll ship as soon as inventory is replenished.

Research-grade material. Documentation summarizes published literature in third-person scientific context. Not medical advice; not for human consumption.

— Pricing —

Three ways to source this compound.

All prices in USDT. Crypto pays settle directly to our wallet.

Single vial

Retail $46 USDT

Member $40.00 USDT

Members save 15% — free to join

1 vial · $40.00 USDT per vial

Most flexible

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

5-Pack

Save 14%

Retail $198 USDT

Member $172.00 USDT

Members save 15% — free to join

5 vials · $34.40 USDT per vial

Researcher's choice

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

10-Pack

Best value

Retail $288 USDT

Member $250.00 USDT

Members save 15% — free to join

10 vials · $25.00 USDT per vial

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

— The literature —

From the research record.

Sermorelin binds the GHRH receptor, a class B G-protein coupled receptor expressed on pituitary somatotrophs and at lower levels in extra-pituitary tissues including the hypothalamus and pancreas. Receptor engagement activates Gas, elevates intracellular cAMP, and stimulates protein kinase A-dependent transcription of the growth hormone gene as well as exocytosis of stored hormone from somatotroph secretory granules.

The native GHRH sequence is cleaved at the position 2 Ala-Asp bond by dipeptidyl peptidase-4, yielding the inactive GHRH (3-29) metabolite within minutes of administration. This rapid clearance limits sermorelin to short receptor-exposure durations, producing single growth hormone pulses with each administration. The pulse pattern recapitulates the dynamics of endogenous GHRH release more faithfully than long-acting analogs, an advantage in research contexts where pulsatile rather than sustained somatotroph activation is desired.

All compounds discussed are intended for research use only. Not for human consumption. Research-context information is educational and does not constitute medical advice.

View the full disclaimer →

— Available strengths —

5mg10mg